Corporate Profile
Press Releases
Events
Presentations
Corporate Governance
Leadership
Committee Composition
Financials and Filings
Stock Information
Information Request
Email Notification
menu
close x
About
Company
Leadership
Collaborations
Contact
Programs
Pipeline
Development Strategy
Clinical Trials
Science
microRNA Platform
Therapeutic Areas
Scientific Publications
Careers
Culture & Values
Job Openings
Investors
Patients
Clinical Trials Overview
Cutaneous T-Cell Lymphoma (CTCL)
Adult T-Cell Lymphoma/Leukemia (ATLL)
Diffuse Large B-Cell Lymphoma (DLBCL)
Chronic Lymphocytic Leukemia (CLL)
Keloids
Clinicians
miRagen Clinical Trials
Cutaneous T-cell Lymphoma (CTCL), MF Subtype – Cobomarsen SOLAR Clinical Trial
ATLL, CLL and DLBCL – Cobomarsen Phase 1 Clinical Trial
Keloids – Remlarsen Phase 2 Clinical Trial
Investors
Press Releases
All Releases
Earnings Releases
Merger Releases
Display:
All Releases
Earnings Releases
Merger Releases
Search Press Releases
Subscribe for Email Alerts
Subscribe to RSS feed
List View
Grid View
Date
Headline
Copyright
2019
,
© Powered By Q4 Inc.